In addition, human immune cells could be detected in the peripheral blood (1.6% of murine cells) and in the tumor microenvironment (15.8% of mouse CD45+CD3+ cells) of NOD/SCID mice after CIK treatment, as evaluated by flow cytometry (Fig 4C). This evidence concerns the gene PTPRC and neoplasm.